5-[4-fluoro-3-(2-methylpropyl)phenyl]-1-methyl-2-(3-methyldibenzofuran-4-yl)pyridin-1-ium
C29H27FNO+ — CID 123195423
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[4-fluoro-3-(2-methylpropyl)phenyl]-1-methyl-2-(3-methyldibenzofuran-4-yl)pyridin-1-ium
5-[4-fluoro-3-(2-methylpropyl)phenyl]-1-methyl-2-(3-methyldibenzofuran-4-yl)pyridin-1-ium (PubChem CID 123195423) has the molecular formula C29H27FNO+ and a molecular weight of 424.54 g/mol. Its IUPAC name is 5-[4-fluoro-3-(2-methylpropyl)phenyl]-1-methyl-2-(3-methyldibenzofuran-4-yl)pyridin-1-ium.
Molecular Properties
| Compound Name | 5-[4-fluoro-3-(2-methylpropyl)phenyl]-1-methyl-2-(3-methyldibenzofuran-4-yl)pyridin-1-ium |
|---|---|
| PubChem CID | 123195423 |
| Molecular Formula | C29H27FNO+ |
| Molecular Weight | 424.54 g/mol |
| Exact Mass | 424.21 |
| IUPAC Name | 5-[4-fluoro-3-(2-methylpropyl)phenyl]-1-methyl-2-(3-methyldibenzofuran-4-yl)pyridin-1-ium |
| SMILES | Cc1ccc2c(oc3ccccc32)c1-c1ccc(-c2ccc(F)c(CC(C)C)c2)c[n+]1C |
| InChI | InChI=1S/C29H27FNO/c1-18(2)15-22-16-20(10-13-25(22)30)21-11-14-26(31(4)17-21)28-19(3)9-12-24-23-7-5-6-8-27(23)32-29(24)28/h5-14,16-18H,15H2,1-4H3/q+1 |
| InChIKey | FNBSJCLIKQSCIH-UHFFFAOYSA-N |
| XLogP | 7.39 |
| TPSA | 17.02 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 1 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 424.54 |
| LogP ≤ 5 | 7.39 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 1 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 123195423 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.